Metabolic syndrome: What is it and what are the implications?

Proceedings of the Nutrition Society

Volumn 64, Issue 3, 2005, Pages 349-357

  Shaw, D I ^a   Hall, W L ^a   Williams, C M ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

Definition; Gender; Metabolic syndrome; Pathophysiology; Prevalence

Indexed keywords

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONFERENCE PAPER; DIET; DYSLIPIDEMIA; EXERCISE; HEALTH CARE COST; HIGH RISK POPULATION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; METABOLIC SYNDROME X; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY;

DIABETES MELLITUS, TYPE 2; HEALTH CARE COSTS; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; INSULIN RESISTANCE; METABOLIC SYNDROME X; OBESITY; PRIMARY PREVENTION; PUBLIC HEALTH;

EID: 23844454255     PISSN: 00296651     EISSN: None     Source Type: Journal    
DOI: 10.1079/PNS2005442     Document Type: Conference Paper

References (44)

1. Alexander C, Landsman P, Teutsch S & Haffner S (2003) NCEP-defined metabolic syndrome, diabetes and the prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 52, 1210-1214.
2. Ascaso J, Romero P, Real J, Lorente R, Maitinez-Vails J & Carmena R (2003) Abdominal obesity, insulin resistance, and metabolic syndrome in a southern European population. European Journal of Internal Medicine 14, 101-106.
3. Balkau B & Charles M (1999) Comment on the provisional report from the WHO consultation. Diabetic Medicine 16, 442-443.
4. Balkau B, Vernay M, Mhamdi L, Novak M, Arondel D, Vol S, Tichet J & Eshwege E (2003) The incidence and persistence of the NCEP (National Cholesterol Education Progam) metabolic syndrome. The French D.E.S.I.R. study. Diabetes Metabolism 29, 526-532.
5. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Bonadonna R & Muggeo M (2003) Prevalence, ancillary clinical features and cardiovascular disease in the metabolic syndrome: the Bruneck study. International Congress Series 1253, 13-17.
6. Carr D, Utzschneider K, Hull R, Kodama K, Retzlaff B, Brunzell J, Shofer J, Fish B, Knopp R & Kahn S (2004) Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 53, 2087-2094.
7. Cefalu W (2001) Insulin resistance: cellular and clinical concepts. Experimental Biology and Medicine 226, 13-26.
8. Chen W, Srinivasan S, Elkasabany A & Berenson G (1999) The association of cardiovascular risk factor clustering related to insulin resistance syndrome (Syndrome X) between young parents and their offspring: the Bogalusa Heart Study. Atherosclerosis 145, 197-205.
9. Cunnane S & Griffin B (2002) Nutrition and metabolism of lipids. In Introduction to Human Nutrition, pp. 81-115 [M Gibney, H Vorster and F Kok, editors]. Oxford: Blackwell Science.
10. Diabetes UK (2004) Diabetes in the UK 2004, pp. 1-27. www.diabetes.org.uk/infocentre/reports/in_the_UK_2004.doc
11. Dowse G & Zimmet P (1993) The thrifty genotype in non-insulin dependent diabetes. British Medical Journal 306, 532-533.
12. European Group for the Study of Insulin Resistance (2002) Frequency of the WHO Metabolic Syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metabolism 28, 364-376.
13. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Journal of the American Medical Association 285, 2486-2497.
14. Ford E, Giles W & Dietz W (2002) Prevalence of the metabolic syndrome amongst US adults: findings from the Third National Health and Nutrition Examination Survey. Journal of the American Medical Association 287, 356-359.
15. Ford ES (2004) The metabolic syndrome and mortality from cardiovascular disease and all causes: findings from the National Health and Nutrition Examination Survey II Mortality Study. Atherosclerosis 173, 309-314.
16. Grundy S (2004a) Metabolic syndrome: Part I. Endocrinology and Metabolism Clinics of North America 33, ix-xi.
17. Grundy S (2004b) Obesity, metabolic syndrome, and cardiovascular disease. Journal of Clinical Endocrinology and Metabolism 89, 2295-2600.
18. Haber E, Ximenes H, Procopio J, Carvalho C, Curi R & Carpinelli A (2002) Pleiotropic effects of fatty acids on pancreatic beta cells. Journal of Cellular Physiology 194, 1-12.
19. Hanson R, Imperatore G, Bennett P & Knowler W (2002) Components of the Metabolic Syndrome and incidence of type 2 diabetes. Diabetes 51, 3120-3127.
20. Hills S, Balkau B, Coppack S, Dekker J, Man A, Natali A, Walker M & Ferrannini E (2004) The EGIR-RISC Study (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): 1. Methodology and objectives. Diabetologia 47, 566-570.
21. Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K & Pyorala K (2004) Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Archives of Internal Medicine 164, 1066-1076.
22. International Obesity Task Force (2004) IOTF Childhood Obesity Report, May 2004. http://www.iotf.org/media/IOTFmay28.pdf
23. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen M & Groop L (2001) Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24, 683-689.
24. James P (2004) Obesity: The worldwide epidemic. Clinics in Dermatology 22, 276-280.
25. Kohen-Avramoglu R, Theriault A & Adeli K (2003) Emergence of the metabolic syndrome in childhood: an epidemiological overview and mechanistic link to dyslipidaemia. Clinical Biochemistry 36, 413-420.
26. Kraegen E, Cooney G, Ye J & Fuler S (2002) Peroxisome proliferator activated receptors, fatty acids and muscle insulin resistance. Journal of the Royal Society of Medicine 95, 14-22.
27. Laaksonen D, Lakka H, Niskanen L, Kaplan G, Salonen J & Lakka T (2002) Metabolic syndrome and development of diabetes mellitus: Application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. American Journal of Epidemiology 156, 1070-1077.
28. Lakka H, Laaksonen D, Lakka T, Niskanen L, Kumpulsalo E, Tuomilehto J & Salonen J (2002) The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. Journal of the American Medical Association 288, 2709-2716.
29. Lobstein T, Baur L & Uauy R (2004) Obesity in children and young people: a crisis in public health. Obesity Reviews 5, 4-85.
30. Malik S, Wong N, Franklin S, Kamath T, L'Italien G, Pio J & Williams R (2004) Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 110, 1245-1250.
31. Nestel P (2004) Nutritional aspects in the causation and management of the metabolic syndrome. Endocrinology and Metabolism Clinics of North America 33, 483-492.
32. Ninomiya J, L'Italien G, Criqui M, Whyte J, Gamst A & Chen R (2004) Association of the metabolic syndrome with history of myocardial infarction and stroke in the third national health and nutrition examination survey. Circulation 109, 42-46.
33. Palaniappan L, Carnethon M, Wang Y, Hanley A, Fortmann S, Haffner S & Wagenknecht L (2004) Predictors of the incident metabolic syndrome in adults. Diabetes Care 27, 788-793.
34. Panagiotakos D, Pitsavos C, Chrysohoou C, Skoumas J, Tousoulis D, Toutouza M, Toutouzas P & Stefanadis C (2004) Impact of lifestyle habits on the prevalence of the metabolic syndrome among Greek adults from the ATTICA study. American Heart Journal 147, 106-112.
35. Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37, 1595-1600.
36. Resnick H, Jones K, Ruotolo G, Jain A, Henderson J, Lu W & Howard B (2003) Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic American Indians. Diabetes Care 26, 861-867.
37. Scuteri A, Najjar SS, Muller DC, Andres R, Hougaku H, Metter EJ & Lakatta EG (2004) Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness. Journal of the American College of Cardiology 43, 1388-1395.
38. Tan C, Ma S, Wai D, Chew S & Tai E (2004) Can we apply the National Cholesterol Education Program Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care 27, 1182-1186.
39. van Oostrom A, Cabezas M & Rabelink T (2002) Insulin resistance and vessel endothelial function. Journal of the Royal Society of Medicine 95, 54-61.
40. Vessby B, Uusitupa M, Hermansen K, Riccardi G, Rivellese A, Tapsell L, et al. (2001) Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU study. Diabetologia 44, 312-319.
41. Weiss R, Dzlura J, Burgert T, Tamborlane W, Taksali S, Yeckel C, et al. (2004) Obesity and the metabolic syndrome in children and adolescents. New England Journal of Medicine 350, 2362-2374.
42. Wilson P (2004) Estimating cardiovascular disease risk and the metabolic syndrome: a Framingham view. Endocrinology and Metabolism Clinics of North America 33, 467-481.
43. World Health Organization (1999) Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus, pp. 1-59. Geneva: WHO.
44. World Health Organization/Food and Agriculture Organization (2003) Diet, Nutrition and the Prevention of Chronic Diseases. WHO Technical Report Series no. 916. Geneva: WHO.